Head-to-head · Cost-Efficiency Index
CoreAge Rx vs WellMedr
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
CoreAge Rx
Anyone optimizing for real value — a transparent flat price you can model for a full year, nationwide, without a bait-and-switch.
Visit CoreAge RxWellMedr
Shoppers who will complete a medical intake before they see a price, in exchange for a brand Ozempic or Zepbound lane and an eight-SKU microdose line on the same account as the compounded plan.
Visit WellMedrThe verdict
CoreAge Rx takes it, leading the Cost-Efficiency Index 94 to 54. Best value in the ranking: both molecules at one flat, all-50 price with no teaser step-ups — the lowest true cost of ownership, not the lowest teaser. WellMedr still earns a C — Shoppers who will complete a medical intake before they see a price, in exchange for a brand Ozempic or Zepbound lane and an eight-SKU microdose line on the same account as the compounded plan.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | CoreAge Rx | WellMedr |
|---|---|---|
| Cost-Efficiency Index | 94/100 | 54/100 |
| Semaglutide / mo | $99/mo | Not disclosed — 12-month lock-in rate only |
| Tirzepatide / mo | $149/mo | Not disclosed — "starting at" only, no standing rate |
| Semaglutide / yr (modeled) | $1,188 | — |
| Tirzepatide / yr (modeled) | $1,788 | — |
| Coverage | All 50 states | 50 states claimed, no list published |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #1 | #319 |
CoreAge Rx
94/100Where the value is
- Flat all-in monthly price — no intro rate that silently triples after month one, so the modeled annual cost is the real cost
- Both compounded semaglutide and tirzepatide on one account at published prices
- Available in all 50 states — no coverage gamble
The tradeoffs
- Not the rock-bottom sticker price — 30 of the 381 priced semaglutide programs we track list a cheaper figure, though most attach a term or a step-up that CoreAge does not
- No FDA-approved brand-name option (compounded only)
WellMedr
54/100Where the value is
- The compounding caveat sits ON the pricing page beside the plan cards rather than in a footer: "Compounded medications are regulated by state Boards of Pharmacy, but are not evaluated by the FDA for safety or efficacy," printed with explicit thyroid C-cell tumor and medullary thyroid carcinoma warnings
- Both halves of the supply chain are named and checkable — OpenLoop Healthcare Partners, PC and its state professional corporations as the prescribing group in the telehealth consent, and Mycelium Pharmacy as the fulfillment pharmacy in the HIPAA notice
- The tirzepatide card states "Same price regardless of dosage," so titrating up does not re-price that plan — the single most common way a cheap first month becomes an expensive fourth one
The tradeoffs
- No standing month-to-month rate is published for either compounded drug. The cards say "Starting At $59 a month" and "Starting At $99 a month," the banner on the same page ties the $59 to "12/month Plans — For Life," and both buttons hand off to an intake app that will not quote anything without a plan already chosen
- Two live landers advertise two different lifetime rates for the same program — /pages/get-started-weight-loss offers "$200 OFF Every Month, or $59/mo on 12/month Plans" while /pages/weightloss-with-wellmedr offers "$150 OFF Every Month, or $88/mo on 12/month Plans," and that second page then shows only the $1,399 and $1,599 brand cards
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.